Gamal-Eldeen Amira M, Amer Hassan, Helmy Wafaa A
Cancer Biology Laboratory, Department of Biochemistry, Division of Genetic Engineering and Biotechnology, National Research Centre, Dokki 12622, Cairo, Egypt.
Chem Biol Interact. 2006 Jul 10;161(3):229-40. doi: 10.1016/j.cbi.2006.03.010. Epub 2006 Apr 6.
Guar gum (G) is a simple characterized branched polysaccharide, which is frequently used in food industries. We prepared the gum C-glycosylated derivative (GG), and its sulphated derivative (SGG), aiming to characterize their cancer chemopreventive, and anti-inflammatory properties. Estimation of cancer chemopreventive activity, specifically anti-initiation, including the modulation of carcinogen metabolism and the antioxidant capacity, revealed that GG was a potent anti-initiator, where it inhibited not only the carcinogen activator enzyme, cytochrome P450 1A (CYP1A), but also induced the carcinogen detoxification enzymes glutathione-S-transferases (GSTs), while SGG inhibited both CYP1A and GSTs. SGG was an effective radical scavenger than GG against hydroxyl, peroxyl, and superoxide anion radicals. GG and SGG were found to modulate the macrophage functions into an anti-inflammatory pattern. Thus, both enhanced the macrophage proliferation and phagocytosis of fluorescein isothiocyanate (FITC)-zymosan; however, they also inhibited strongly the nitric oxide generation and tumor necrosis factor-alpha secretion in lipopolysaccharide (LPS)-stimulated RAW macrophage 264.7. Unexpectedly, both GG and SGG dramatically inhibited the binding affinity of FITC-LPS to RAW 264.7, as indicated by flow cytometry analysis. GG and SGG exhibited a significant anti-proliferative activity against human hepatocellular carcinoma cells (Hep G2), and only SGG was specifically cytotoxic for human breast carcinoma cells (MCF-7), but neither was significantly cytotoxic for human lymphoblastic leukemia cells (1301). SGG led to a major disturbance in cell cycle phases of Hep G2 cells as indicated by concomitant arrest in S- and G2/M-phases, a disturbance that was associated with an induced cell death as a result of necrosis, but not apoptosis in both GG- and SGG-treated cells. Taken together, the modified gums could be used as an alternative of G in health food industries to provide cancer prevention in risk populations.
瓜尔胶(G)是一种结构简单的分支多糖,常用于食品工业。我们制备了瓜尔胶的C-糖基化衍生物(GG)及其硫酸化衍生物(SGG),旨在表征它们的癌症化学预防和抗炎特性。对癌症化学预防活性的评估,特别是抗启动活性,包括对致癌物代谢的调节和抗氧化能力,结果显示GG是一种有效的抗启动剂,它不仅抑制致癌物激活酶细胞色素P450 1A(CYP1A),还诱导致癌物解毒酶谷胱甘肽-S-转移酶(GSTs),而SGG则同时抑制CYP1A和GSTs。与GG相比,SGG是一种更有效的针对羟基、过氧自由基和超氧阴离子自由基的自由基清除剂。发现GG和SGG可将巨噬细胞功能调节为抗炎模式。因此,二者均增强了巨噬细胞的增殖以及异硫氰酸荧光素(FITC)-酵母聚糖的吞噬作用;然而,它们也强烈抑制脂多糖(LPS)刺激的RAW巨噬细胞264.7中一氧化氮的产生和肿瘤坏死因子-α的分泌。出乎意料的是,流式细胞术分析表明,GG和SGG均显著抑制FITC-LPS与RAW 264.7的结合亲和力。GG和SGG对人肝癌细胞(Hep G2)表现出显著的抗增殖活性,只有SGG对人乳腺癌细胞(MCF-7)具有特异性细胞毒性,但二者对人淋巴细胞白血病细胞(1301)均无显著细胞毒性。如S-期和G2/M期的同时阻滞所示,SGG导致Hep G2细胞的细胞周期阶段出现重大紊乱,这种紊乱与坏死诱导的细胞死亡有关,而在GG和SGG处理的细胞中均未出现凋亡。综上所述,这些改性胶可在保健食品工业中用作瓜尔胶的替代品,为高危人群提供癌症预防作用。